NONOF vs JNJ: Which Stock is Better?
Side-by-side comparison of Novo Nordisk A/S and Johnson & Johnson in 2026
NONOF
Novo Nordisk A/S
—
JNJ
Johnson & Johnson
$232.77
Key Metrics Comparison
| Metric | NONOF | JNJ | Winner |
|---|---|---|---|
| Market Cap | $317.17B | $375.37B | JNJ |
| P/E Ratio | 18.73 | 17.35 | JNJ |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze NONOF
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is NONOF or JNJ a better investment?
Comparing NONOF and JNJ: Novo Nordisk A/S has a market cap of $317.17B while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between NONOF and JNJ?
NONOF (Novo Nordisk A/S) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: NONOF or JNJ?
Based on P/E ratios, JNJ trades at a lower multiple (17.4x vs 18.7x).
Which is growing faster: NONOF or JNJ?
Both NONOF and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: NONOF or JNJ?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: NONOF or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $317.17B for NONOF.
Should I buy NONOF or JNJ in 2026?
Both NONOF and JNJ have investment merit. NONOF trades at $N/A while JNJ trades at $232.77. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between NONOF and JNJ stock?
Key differences: Market Cap ($317.17B vs $375.37B), P/E Ratio (18.7x vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy NONOF or JNJ in 2026?
The choice between NONOF and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between NONOF and JNJ?
NONOF (Novo Nordisk A/S) has a market cap of $317.17B, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.